{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:59:16Z","timestamp":1785113956435,"version":"3.55.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","award":["123S068"],"award-info":[{"award-number":["123S068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50820-8","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:45:02Z","timestamp":1779363902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of adjuvant propofol on antitumoral effects of carboplatin in experimental endometrial cancer: possible epigenetic associations"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0266-2115","authenticated-orcid":false,"given":"\u00c7evik","family":"G\u00fcrel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1750-8209","authenticated-orcid":false,"given":"G\u00f6k\u00e7e Ceren","family":"Ku\u015f\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3759-6616","authenticated-orcid":false,"given":"Aylin","family":"Buhur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4358-6510","authenticated-orcid":false,"given":"Saadet \u00d6zen","family":"Akarca Dizakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4304-3727","authenticated-orcid":false,"given":"Hale","family":"G\u00fcler Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6856-4644","authenticated-orcid":false,"given":"Neslihan P\u0131nar","family":"\u00d6zate\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0605-4750","authenticated-orcid":false,"given":"Nuri","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8719-0358","authenticated-orcid":false,"given":"\u0130lkben","family":"G\u00fcn\u00fc\u015fen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"50820_CR1","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3390\/jcm14041385","volume":"14","author":"MBB Anca-Stanciu","year":"2025","unstructured":"Anca-Stanciu, M. B. B. et al. Comprehensive review of endometrial cancer: New molecular and FIGO classification and recent treatment changes. J. Clin. Med. 14, 1385 (2025).","journal-title":"J. Clin. Med."},{"key":"50820_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2147\/IJWH.S499435","volume":"17","author":"S Gao","year":"2025","unstructured":"Gao, S., Wang, J., Li, Z., Wang, T. & Wang, J. Global trends in incidence and mortality rates of endometrial cancer among individuals aged 55 years and above from 1990 to 2021: An analysis of the global burden of disease. Int. J. Womens Health. 17, 651\u2013662 (2025).","journal-title":"Int. J. Womens Health"},{"key":"50820_CR3","doi-asserted-by":"publisher","first-page":"100895","DOI":"10.1016\/j.currproblcancer.2022.100895","volume":"46","author":"V Garg","year":"2022","unstructured":"Garg, V., Jayaraj, A. S. & Kumar, L. Novel approaches for treatment of endometrial carcinoma. Curr. Probl. Cancer. 46, 100895 (2022).","journal-title":"Curr. Probl. Cancer"},{"key":"50820_CR4","doi-asserted-by":"crossref","unstructured":"Menendez-Santos, M. et al. Endometrial cancer: 2023 revised FIGO staging system and the role of imaging. Cancers (Basel) 16, 1869 (2024).","DOI":"10.3390\/cancers16101869"},{"key":"50820_CR5","doi-asserted-by":"crossref","unstructured":"Du, Q. et al. Propofol inhibits proliferation, migration, and invasion but promotes apoptosis by regulation of Sox4 in endometrial cancer cells. Brazilian J. Med. Biol. Res 51, e6803 (2018).","DOI":"10.1590\/1414-431x20176803"},{"key":"50820_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/ijgc-2019-000822","volume":"30","author":"F Legge","year":"2020","unstructured":"Legge, F. et al. Clinical outcome of recurrent endometrial cancer: Analysis of post-relapse survival by pattern of recurrence and secondary treatment. Int. J. Gynecol. Cancer. 30, 193\u2013200 (2020).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"50820_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s11864-025-01314-8","volume":"26","author":"E Hicks","year":"2025","unstructured":"Hicks, E., Shah, A. & Higgins, R. V. Therapeutic challenges in the management of serous endometrial intraepithelial carcinoma (SEIC). Curr. Treat. Options Oncol. 26, 341\u2013347 (2025).","journal-title":"Curr. Treat. Options Oncol."},{"key":"50820_CR8","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00432-021-03566-x","volume":"147","author":"G Dinoi","year":"2021","unstructured":"Dinoi, G. et al. In search for biomarkers and potential drug targets for uterine serous endometrial cancer. J. Cancer Res. Clin. Oncol. 147, 1647\u20131658 (2021).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"50820_CR9","doi-asserted-by":"crossref","unstructured":"Yan, L., Ding, X., Deng, Y., Li, Y. & Du, X. The molecular classification ushers in a new era for the treatment of advanced and recurrent endometrial cancer. Front Oncol 15, 176115 (2026).","DOI":"10.3389\/fonc.2025.1761159"},{"key":"50820_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/curroncol32050251","volume":"32","author":"A Svarna","year":"2025","unstructured":"Svarna, A. et al. Molecular prognostic factors in uterine serous carcinomas: A systematic review. Curr. Oncol. 32, 251 (2025).","journal-title":"Curr. Oncol."},{"key":"50820_CR11","doi-asserted-by":"publisher","first-page":"1505071","DOI":"10.3389\/fmed.2024.1505071","volume":"11","author":"Z Niu","year":"2025","unstructured":"Niu, Z. et al. MTFR2 promotes endometrial carcinoma cell proliferation and growth via the miR-132-3p\/PI3K\/Akt signaling pathway. Front. Med. 11, 1505071 (2025).","journal-title":"Front. Med."},{"key":"50820_CR12","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.3390\/cancers14235748","volume":"14","author":"LA de Rooij","year":"2022","unstructured":"de Rooij, L. A. et al. The microRNA lifecycle in health and cancer. Cancers (Basel). 14, 5748 (2022).","journal-title":"Cancers (Basel)"},{"key":"50820_CR13","doi-asserted-by":"publisher","first-page":"13340","DOI":"10.3390\/ijms241713340","volume":"24","author":"AA Seyhan","year":"2023","unstructured":"Seyhan, A. A. Circulating microRNAs as potential biomarkers in pancreatic cancer\u2014advances and challenges. Int. J. Mol. Sci. 24, 13340 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"50820_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3390\/cancers13051137","volume":"13","author":"A Favier","year":"2021","unstructured":"Favier, A. et al. MicroRNA as epigenetic modifiers in endometrial cancer: A systematic review. Cancers (Basel). 13, 1137 (2021).","journal-title":"Cancers (Basel)"},{"key":"50820_CR15","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.3390\/ijms241411489","volume":"24","author":"A Bogaczyk","year":"2023","unstructured":"Bogaczyk, A. et al. The role of miRNAs in the development, proliferation, and progression of endometrial cancer. Int. J. Mol. Sci. 24, 11489 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"50820_CR16","first-page":"11489","volume":"10","author":"W Zhao","year":"2017","unstructured":"Zhao, W., Geng, P., Li, Y., Wei, X. & Cheng, J. MicroRNA-21 promotes endometrial carcinoma proliferation and invasion by targeting PTEN. Int. J. Clin. Exp. Pathol. 10, 11489 (2017).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"50820_CR17","first-page":"100103","volume":"5","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. MicroRNA-135a promotes proliferation, migration, invasion and induces chemoresistance of endometrial cancer cells. Eur. J. Obstet. Gynecol. Reprod. Biol. X. 5, 100103 (2020).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. X"},{"key":"50820_CR18","first-page":"4213","volume":"16","author":"J Li","year":"2018","unstructured":"Li, J., Sun, H., Liu, T. & Kong, J. MicroRNA-423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells. Exp. Ther. Med. 16, 4213\u20134224 (2018).","journal-title":"Exp. Ther. Med."},{"key":"50820_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1620\/tjem.251.263","volume":"251","author":"I Sato","year":"2020","unstructured":"Sato, I. et al. MicroRNA Let-7c contributes to paclitaxel resistance via aurora-B in endometrial serous carcinoma. Tohoku J. Exp. Med. 251, 263\u2013272 (2020).","journal-title":"Tohoku J. Exp. Med."},{"key":"50820_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3892\/ijo.2015.2986","volume":"47","author":"N Yamamoto","year":"2015","unstructured":"Yamamoto, N. et al. The tumor-suppressive microRNA-1\/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer. Int. J. Oncol. 47, 325\u2013334 (2015).","journal-title":"Int. J. Oncol."},{"key":"50820_CR21","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.2147\/OTT.S190282","volume":"12","author":"H Meng","year":"2019","unstructured":"Meng, H. et al. MiR-449a regulates the cell migration and invasion of human non-small cell lung carcinoma by targeting ADAM10. Onco Targets Ther. 12, 3829 (2019).","journal-title":"Onco Targets Ther."},{"key":"50820_CR22","first-page":"1145","volume":"57","author":"M Yanokura","year":"2020","unstructured":"Yanokura, M., Banno, K. & Aoki, D. MicroRNA\u201334b expression enhances chemosensitivity of endometrial cancer cells to paclitaxel. Int. J. Oncol. 57, 1145\u20131156 (2020).","journal-title":"Int. J. Oncol."},{"key":"50820_CR23","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.3389\/fonc.2021.809410","volume":"11","author":"W Huang","year":"2021","unstructured":"Huang, W. et al. A Novel miR-98 negatively regulates the resistance of endometrial cancer cells to paclitaxel by suppressing ABCC10\/MRP-7. Front. Oncol. 11, 5098 (2021).","journal-title":"Front. Oncol."},{"key":"50820_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1158\/1535-7163.MCT-08-1046","volume":"8","author":"DR Cochrane","year":"2009","unstructured":"Cochrane, D. R., Spoelstra, N. S., Howe, E. N., Nordeen, S. K. & Richer, J. K. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol. Cancer Ther. 8, 1055\u20131066 (2009).","journal-title":"Mol. Cancer Ther."},{"key":"50820_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1021\/acsptsci.4c00745","volume":"8","author":"M Kazi","year":"2025","unstructured":"Kazi, M. et al. Propofol: Current updates, challenges, and strategies for improved self-nanoemulsifying formulation. ACS Pharmacol. Transl Sci. 8, 1013\u20131027 (2025).","journal-title":"ACS Pharmacol. Transl Sci."},{"key":"50820_CR26","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.3390\/cancers16244269","volume":"16","author":"H Choi","year":"2024","unstructured":"Choi, H. & Hwang, W. Anesthetic approaches and their impact on cancer recurrence and metastasis: A comprehensive review. Cancers (Basel). 16, 4269 (2024).","journal-title":"Cancers (Basel)"},{"key":"50820_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejphar.2018.04.009","volume":"831","author":"S Jiang","year":"2018","unstructured":"Jiang, S., Liu, Y., Huang, L., Zhang, F. & Kang, R. Effects of propofol on cancer development and chemotherapy: Potential mechanisms. Eur. J. Pharmacol. 831, 46\u201351 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"50820_CR28","doi-asserted-by":"publisher","first-page":"117280","DOI":"10.1016\/j.lfs.2020.117280","volume":"244","author":"YF Zhang","year":"2020","unstructured":"Zhang, Y. F., Li, C. S., Zhou, Y. & Lu, X. H. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1\/miR-30e\/ATG5 axis through suppressing autophagy in gastric cancer. Life Sci. 244, 117280 (2020).","journal-title":"Life Sci."},{"key":"50820_CR29","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.3748\/wjg.v19.i33.5485","volume":"19","author":"QH Du","year":"2013","unstructured":"Du, Q. H., Xu, Y. B., Zhang, M. Y., Yun, P. & He, C. Y. Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells in vitro by inhibition of nuclear factor-\u03baB activity. World J. Gastroenterol. 19, 5485 (2013).","journal-title":"World J. Gastroenterol."},{"key":"50820_CR30","first-page":"6446","volume":"25","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Propofol inhibits invasion and enhances paclitaxel-induced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug (European review for medical and pharmacological sciences (2013) 17 13 (1722\u20131729) PII: 27139). Eur. Rev. Med. Pharmacol. Sci. 25, 6446 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"50820_CR31","first-page":"e919786","volume":"26","author":"Y Huang","year":"2020","unstructured":"Huang, Y., Lei, L. & Liu, Y. Propofol improves sensitivity of lung cancer cells to cisplatin and its mechanism. Med. Sci. Monit. 26, e919786\u2013e919781 (2020).","journal-title":"Med. Sci. Monit."},{"key":"50820_CR32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ygyno.2008.01.028","volume":"109","author":"D Pectasides","year":"2008","unstructured":"Pectasides, D. et al. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer. Gynecol. Oncol. 109, 250\u2013254 (2008).","journal-title":"Gynecol. Oncol."},{"key":"50820_CR33","first-page":"3793","volume":"34","author":"SH Tirmazy","year":"2014","unstructured":"Tirmazy, S. H., Barthakur, U., El-Modir, A., Anwar, S. & Fernando, I. Chemotherapy for advanced endometrial cancer with carboplatin and epirubicin. Anticancer Res. 34, 3793\u20133798 (2014).","journal-title":"Anticancer Res."},{"key":"50820_CR34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ygyno.2013.11.027","volume":"132","author":"SB Korets","year":"2014","unstructured":"Korets, S. B., Musa, F., Curtin, J., Blank, S. V. & Schneider, R. J. Dual mTORC1\/2 inhibition in a preclinical xenograft tumor model of endometrial cancer. Gynecol. Oncol. 132, 468\u2013473 (2014).","journal-title":"Gynecol. Oncol."},{"key":"50820_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/ijms20020304","volume":"20","author":"M Moskot","year":"2019","unstructured":"Moskot, M. et al. The role of dimethyl sulfoxide (DMSO) in gene expression modulation and glycosaminoglycan metabolism in lysosomal storage disorders on an example of mucopolysaccharidosis. Int. J. Mol. Sci. 20, 304 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"50820_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0300060520925352","volume":"48","author":"Y Fan","year":"2020","unstructured":"Fan, Y. et al. NLRC5 promotes cell migration and invasion by activating the PI3K\/AKT signaling pathway in endometrial cancer. J. Int. Med. Res. 48, 1\u201313 (2020).","journal-title":"J. Int. Med. Res."},{"key":"50820_CR37","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jid.2016.11.020","volume":"137","author":"A Grada","year":"2017","unstructured":"Grada, A., Otero-Vinas, M., Prieto-Castrillo, F., Obagi, Z. & Falanga, V. Research techniques made simple: Analysis of collective cell migration using the wound healing assay. J. Invest. Dermatol. 137, e11\u2013e16 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"50820_CR38","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1038\/s41418-023-01221-1","volume":"30","author":"J Shen","year":"2023","unstructured":"Shen, J. et al. The E3 ubiquitin ligase TRIM17 promotes gastric cancer survival and progression via controlling BAX stability and antagonizing apoptosis. Cell. Death Differ. 30, 2322\u20132335 (2023).","journal-title":"Cell. Death Differ."},{"key":"50820_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/1471-2407-11-425","volume":"11","author":"F Jiang","year":"2011","unstructured":"Jiang, F. et al. MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo. BMC Cancer. 11, 425 (2011).","journal-title":"BMC Cancer"},{"key":"50820_CR40","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1158\/1535-7163.MCT-15-0032","volume":"14","author":"Y Kwak","year":"2015","unstructured":"Kwak, Y., Cho, H., Hur, W. & Sim, T. Antitumor effects and mechanisms of AZD4547 on FGFR2-deregulated endometrial cancer cells. Mol. Cancer Ther. 14, 2292\u20132302 (2015).","journal-title":"Mol. Cancer Ther."},{"key":"50820_CR41","doi-asserted-by":"crossref","unstructured":"Qiu, M. T. et al. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1. Oncotarget 6, 31702 (2015).","DOI":"10.18632\/oncotarget.5165"},{"key":"50820_CR42","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.canlet.2014.09.036","volume":"356","author":"AM Friel","year":"2015","unstructured":"Friel, A. M. et al. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors. Cancer Lett. 356, 434\u2013442 (2015).","journal-title":"Cancer Lett."},{"key":"50820_CR43","doi-asserted-by":"publisher","DOI":"10.3791\/57648","author":"K Young","year":"2018","unstructured":"Young, K. & Morrison, H. Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using imageJ. J. Vis. Exp. https:\/\/doi.org\/10.3791\/57648 (2018).","journal-title":"J. Vis. Exp."},{"key":"50820_CR44","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1007\/s12094-025-04046-1","volume":"27","author":"SP Ram\u00edrez","year":"2025","unstructured":"Ram\u00edrez, S. P. et al. SEOM-GEICO clinical guidelines on endometrial cancer (2025). Clin. Transl Oncol. 27, 4368\u20134380 (2025).","journal-title":"Clin. Transl Oncol."},{"key":"50820_CR45","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3390\/cancers17071240","volume":"17","author":"F Pagano","year":"2025","unstructured":"Pagano, F. et al. Intraoperative radiation therapy for gynecologic malignancies: When is it indicated? Cancers (Basel). 17, 1240 (2025).","journal-title":"Cancers (Basel)"},{"key":"50820_CR46","doi-asserted-by":"crossref","unstructured":"Wu, Z., Wang, H., Shi, Z. A. & Li, Y. Propofol prevents the growth, migration, invasion, and glycolysis of colorectal cancer cells by downregulating lactate dehydrogenase both in vitro and in vivo. J. Oncol. 1\u201311 (2022). (2022).","DOI":"10.1155\/2022\/8317466"},{"key":"50820_CR47","doi-asserted-by":"crossref","unstructured":"Zoroddu, S., Sias, F. & Bagella, L. The double life of microRNAs in bone sarcomas: oncogenic drivers and tumor suppressors. Int. J. Mol. Sci 26, 4814 (2025).","DOI":"10.3390\/ijms26104814"},{"key":"50820_CR48","doi-asserted-by":"publisher","first-page":"e3100","DOI":"10.1038\/cddis.2017.495","volume":"8","author":"E Slab\u00e1kov\u00e1","year":"2017","unstructured":"Slab\u00e1kov\u00e1, E., Culig, Z., Rem\u0161\u00edk, J. & Sou\u010dek, K. Alternative mechanisms of miR-34a regulation in cancer. Cell. Death Dis. 8, e3100\u2013e3100 (2017).","journal-title":"Cell. Death Dis."},{"key":"50820_CR49","doi-asserted-by":"publisher","first-page":"155091","DOI":"10.1016\/j.prp.2024.155091","volume":"254","author":"HS Chawra","year":"2024","unstructured":"Chawra, H. S. et al. MicroRNA-21\u2019s role in PTEN suppression and PI3K\/AKT activation: Implications for cancer biology. Pathol. Res. Pract. 254, 155091 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"50820_CR50","first-page":"6617","volume":"8","author":"X Ran","year":"2015","unstructured":"Ran, X. et al. MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy. Int. J. Clin. Exp. Pathol. 8, 6617\u20136626 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"50820_CR51","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.4238\/2015.July.3.28","volume":"14","author":"ZT Wang","year":"2015","unstructured":"Wang, Z. T., Gong, H. Y., Zheng, F., Liu, D. J. & Dong, T. L. Propofol suppresses proliferation and invasion of pancreatic cancer cells by upregulating microRNA-133a expression. Genet. Mol. Res. 14, 7529\u20137537 (2015).","journal-title":"Genet. Mol. Res."},{"key":"50820_CR52","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/bcpt.13224","volume":"125","author":"X Yu","year":"2019","unstructured":"Yu, X., Gao, Y. & Zhang, F. Propofol inhibits pancreatic cancer proliferation and metastasis by up-regulating miR\u2010328 and down\u2010regulating ADAM8. Basic. Clin. Pharmacol. Toxicol. 125, 271\u2013278 (2019).","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"50820_CR53","doi-asserted-by":"publisher","first-page":"e5717","DOI":"10.1590\/1414-431x20165717","volume":"49","author":"X Huang","year":"2016","unstructured":"Huang, X., Teng, Y., Yang, H. & Ma, J. Propofol inhibits invasion and growth of ovarian cancer cells via regulating miR-9\/NF-\u03baB signal. Brazilian J. Med. Biol. Res. 49, e5717 (2016).","journal-title":"Brazilian J. Med. Biol. Res."},{"key":"50820_CR54","first-page":"4120","volume":"8","author":"Z Liu","year":"2016","unstructured":"Liu, Z. et al. Propofol inhibits growth and invasion of pancreatic cancer cells through regulation of the miR-21\/Slug signaling pathway. Am. J. Transl Res. 8, 4120\u20134133 (2016).","journal-title":"Am. J. Transl Res."},{"key":"50820_CR55","first-page":"1471","volume":"21","author":"Y Sun","year":"2020","unstructured":"Sun, Y. et al. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA\u2013374a\/forkhead box O1 signaling axis. Mol. Med. Rep. 21, 1471\u20131480 (2020).","journal-title":"Mol. Med. Rep."},{"key":"50820_CR56","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/OTT.S123085","volume":"10","author":"X Luan","year":"2017","unstructured":"Luan, X., Ma, C., Wang, P. & Lou, F. HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition. Onco Targets Ther. 10, 1389\u20131402 (2017).","journal-title":"Onco Targets Ther."},{"key":"50820_CR57","doi-asserted-by":"publisher","first-page":"28042","DOI":"10.18632\/oncotarget.15886","volume":"8","author":"Z Zhuo","year":"2017","unstructured":"Zhuo, Z. & Yu, H. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells. Oncotarget 8, 28042\u201328051 (2017).","journal-title":"Oncotarget"},{"key":"50820_CR58","doi-asserted-by":"publisher","first-page":"837974","DOI":"10.3389\/fonc.2022.837974","volume":"12","author":"C Sun","year":"2022","unstructured":"Sun, C., Liu, P., Pei, L., Zhao, M. & Huang, Y. Propofol inhibits proliferation and augments the anti-tumor effect of doxorubicin and paclitaxel partly through promoting ferroptosis in triple-negative breast cancer cells. Front. Oncol. 12, 837974 (2022).","journal-title":"Front. Oncol."},{"key":"50820_CR59","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.21037\/tcr-21-830","volume":"10","author":"X Hu","year":"2021","unstructured":"Hu, X., Hu, X. & Wang, Q. Propofol induces apoptosis of hepatocellular carcinoma cells by upregulating miR-134 expression. Transl Cancer Res. 10, 3004\u20133012 (2021).","journal-title":"Transl Cancer Res."},{"key":"50820_CR60","first-page":"64","volume":"124","author":"E Gonullu","year":"2023","unstructured":"Gonullu, E., Dagistan, G., Erkin, Y., Erdogan, M. A. & Erbas, O. Demonstration of the protective effect of propofol in rat model of cisplatin-induced neuropathy. Bratisl Lek Listy. 124, 64\u201369 (2023).","journal-title":"Bratisl Lek Listy"},{"key":"50820_CR61","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","volume":"59","author":"V Lakics","year":"2010","unstructured":"Lakics, V., Karran, E. H. & Boess, F. G. Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology 59, 367\u2013374 (2010).","journal-title":"Neuropharmacology"},{"key":"50820_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3727\/000000006783991962","volume":"13","author":"YS Lin","year":"2006","unstructured":"Lin, Y. S. et al. Gene expression profiles of the aurora family kinases. Gene Expr. 13, 15 (2006).","journal-title":"Gene Expr"},{"key":"50820_CR63","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ygyno.2011.10.011","volume":"124","author":"YJ Ioffe","year":"2012","unstructured":"Ioffe, Y. J., Chiappinelli, K. B., Mutch, D. G., Zighelboim, I. & Goodfellow, P. J. Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis? Gynecol. Oncol. 124, 340 (2012).","journal-title":"Gynecol. Oncol."},{"key":"50820_CR64","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1093\/nar\/gkp196","volume":"37","author":"N Kumar","year":"2009","unstructured":"Kumar, N., Basundra, R. & Maiti, S. Elevated polyamines induce c-MYC overexpression by perturbing quadruplex\u2013WC duplex equilibrium. Nucleic Acids Res. 37, 3321 (2009).","journal-title":"Nucleic Acids Res."},{"key":"50820_CR65","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1111\/j.1582-4934.2008.00433.x","volume":"13","author":"G Kotzamanis","year":"2009","unstructured":"Kotzamanis, G. et al. CFTR expression from a BAC carrying the complete human gene and associated regulatory elements. J. Cell. Mol. Med. 13, 2938 (2009).","journal-title":"J. Cell. Mol. Med."},{"key":"50820_CR66","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3892\/ol.2013.1132","volume":"5","author":"J Zhang","year":"2013","unstructured":"Zhang, J., Zhang, L. L., Shen, L., Xu, X. M. & Yu, H. G. Regulation of AKT gene expression by cisplatin. Oncol. Lett. 5, 756 (2013).","journal-title":"Oncol. Lett."},{"key":"50820_CR67","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s12253-016-0066-5","volume":"22","author":"I Riquelme","year":"2016","unstructured":"Riquelme, I. et al. The gene expression status of the PI3K\/AKT\/mTOR pathway in gastric cancer tissues and cell lines. Pathol. Oncol. Res. 22, 797 (2016).","journal-title":"Pathol. Oncol. Res."},{"key":"50820_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1757-7241-20-61","volume":"20","author":"C Wu","year":"2012","unstructured":"Wu, C. et al. Evaluation of high mobility group box 1 protein as a presurgical diagnostic marker reflecting the severity of acute appendicitis. Scand. J. Trauma. Resusc. Emerg. Med. 20, 61 (2012).","journal-title":"Scand. J. Trauma. Resusc. Emerg. Med."},{"key":"50820_CR69","first-page":"695","volume":"40","author":"M Shibazaki","year":"2012","unstructured":"Shibazaki, M. et al. Transcriptional and post-transcriptional regulation of \u03b2III-tubulin protein expression in relation with cell cycle-dependent regulation of tumor cells. Int. J. Oncol. 40, 695\u2013702 (2012).","journal-title":"Int. J. Oncol."},{"key":"50820_CR70","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3892\/ol.2017.5645","volume":"13","author":"H Sun","year":"2017","unstructured":"Sun, H. et al. Overexpression of N-cadherin and \u03b2-catenin correlates with poor prognosis in patients with nasopharyngeal carcinoma. Oncol. Lett. 13, 1725 (2017).","journal-title":"Oncol. Lett."},{"key":"50820_CR71","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.3892\/mmr.2015.3246","volume":"11","author":"L Sun","year":"2015","unstructured":"Sun, L. et al. Expression of circulating microRNA-1 and microRNA-133 in pediatric patients with tachycardia. Mol. Med. Rep. 11, 4039 (2015).","journal-title":"Mol. Med. Rep."},{"key":"50820_CR72","first-page":"1","volume":"2018 504 50","author":"GX Liu","year":"2018","unstructured":"Liu, G. X. et al. Hsa-let-7c controls the committed differentiation of IGF-1-treated mesenchymal stem cells derived from dental pulps by targeting IGF-1R via the MAPK pathways. Exp. Mol. Med. 2018 504 50, 1\u201314 (2018).","journal-title":"Exp. Mol. Med."},{"key":"50820_CR73","first-page":"4237","volume":"17","author":"F Yan","year":"2018","unstructured":"Yan, F., Wang, C., Li, T., Cai, W. & Sun, J. Role of miR-21 in the growth and metastasis of human salivary adenoid cystic carcinoma. Mol. Med. Rep. 17, 4237\u20134244 (2018).","journal-title":"Mol. Med. Rep."},{"key":"50820_CR74","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1080\/15384101.2020.1829824","volume":"19","author":"H Yang","year":"2020","unstructured":"Yang, H. et al. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer. Cell. Cycle. 19, 2939\u20132954 (2020).","journal-title":"Cell. Cycle"},{"key":"50820_CR75","first-page":"2038","volume":"23","author":"XF Zhuang","year":"2019","unstructured":"Zhuang, X. F. et al. miR-34b inhibits the migration\/invasion and promotes apoptosis of non-small-cell lung cancer cells by YAF2. Eur. Rev. Med. Pharmacol. Sci. 23, 2038\u20132046 (2019).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"50820_CR76","doi-asserted-by":"crossref","unstructured":"Zhu, Y. et al. miR-98-5p alleviated epithelial-to-mesenchymal transition and renal fibrosis via targeting Hmga2 in diabetic nephropathy. Int. J. Endocrinol. 4946181 (2019). (2019).","DOI":"10.1155\/2019\/4946181"},{"key":"50820_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-12-111","volume":"12","author":"Y Chen","year":"2012","unstructured":"Chen, Y. et al. MiRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10. BMC Cancer. 12, 1\u201311 (2012).","journal-title":"BMC Cancer"},{"key":"50820_CR78","first-page":"209","volume":"21","author":"Z Liu","year":"2020","unstructured":"Liu, Z., Mao, L., Wang, L., Zhang, H. & Hu, X. miR-218 functions as a tumor suppressor gene in cervical cancer. Mol. Med. Rep. 21, 209 (2020).","journal-title":"Mol. Med. Rep."},{"key":"50820_CR79","first-page":"5767","volume":"15","author":"C Wang","year":"2018","unstructured":"Wang, C., Kang, L., Wang, X., Liu, Y. & Zhao, X. Expression of miR-200a and chemotherapeutic treatment efficacy of glioma. Oncol. Lett. 15, 5767 (2018).","journal-title":"Oncol. Lett."},{"key":"50820_CR80","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1186\/s12885-020-07478-w","volume":"20","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Upregulation of miR-205 induces CHN1 expression, which is associated with the aggressive behaviour of cervical cancer cells and correlated with lymph node metastasis. BMC Cancer. 20, 1029 (2020).","journal-title":"BMC Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50820-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50820-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50820-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:02:48Z","timestamp":1785110568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50820-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50820"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50820-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8989395\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Ege University Animal Experimentation Local Ethics Committee (Approval Number: 2023-019; Approval Date: March 29, 2023), and was conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. All procedures were conducted in accordance with the ARRIVE Guideline 2.0.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"23236"}}